Dermatologic Surgery · 2020 · 17 citations · 4 references
PharmacyPharmacologyPharmacotherapyClinical PharmacologyHypersensitivityNeurotoxicologyDrug-induced Skin ReactionsSkin SafetyTopical PreparationsInjection-related Adverse EventsMedication-related Adverse EventsNeurotoxin InjectionsOily SkinPlacebo-controlled Efficacy AssessmentSubjectsTreatment Of Facial Rhytides
BACKGROUND: AbobotulinumtoxinA has been investigated for applications beyond facial rhytides, including the treatment of oily skin. OBJECTIVE: The authors sought to investigate the optimal number of units and the duration of abobotulinumtoxinA for the treatment of oily skin. MATERIALS AND METHODS: This randomized, double-blinded, placebo-controlled study included 50 male and female subjects that got either 0, 15, 30, or 45 units of abobotulinumtoxinA injected into their forehead. For the 6 months after treatment, subjects were evaluated for the effectiveness of the treatment in decreasing the oiliness of their skin and the duration of this effect. RESULTS: Subjects in the treatment groups that received either 30 or 45 units of neurotoxin experienced a significant reduction in oily skin. This effect was present for the 6-month duration of the study. No treatment-related adverse events were reported during this study, and both subjects and investigators reported a high level of satisfaction with the treatment. CONCLUSION: Thirty or 45 units of abobotulinumtoxinA are safe and effective doses in treating oily skin for improved cosmetic appearance.
4
Use of intradermal botulinum toxin to reduce sebum production and facial pore size.
Anil Shah · PubMed · 2008 · 93 citations
Medicine, Dermatology, Allergy +13
Peiru Min, Wenjing Xi, Luca Grassetti et al. · Aesthetic Surgery Journal · 2015 · 53 citations · Full text